BusinessCannabis Science Announces the Second Frontiers Peer-Reviewed Publication of its Research Results on the Use of Cannabinoids in the Treatment of CancersBy Nasdaq OMXMay 1, 2018, 11:44 AM UTC
BusinessCannabis Science Groundbreaking Cancer Research Skyrockets With More Views Than 95% of All Frontiers Articles; Research Team Begins Evaluating Commercialization OptionsBy Nasdaq OMXFeb 22, 2018, 12:39 PM UTC
BusinessCannabis Science Announces an Overwhelming Response to its Groundbreaking Research on the Use of Cannabinoids in the Treatment of Cancers, Already Has More Views Than 91% of the Papers Published in all Frontiers JournalsBy Nasdaq OMXJan 18, 2018, 1:23 PM UTC
